series-c-plus
Stage
2016
Founded
1
Investors
About
JW Therapeutics is a biotechnology company focused on developing, manufacturing, and commercializing cell immunotherapy products for hematologic malignancies, solid tumors, and autoimmune diseases.
Explore JW Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.